Nucleos(t)ide Analogues: Clinical Trials

5 trials of Nucleos(t)ide Analogues, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 2 not yet recruiting. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Unknown 2, Not yet recruiting 1

Follow Nucleos(t)ide Analogues: new trials by email Literature Review of Nucleos(t)ide Analogues trials Research Report on Nucleos(t)ide Analogues

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sequential PD-1 Antibody and Pegylated Interferon Therapy for Nucleos(t)Ide Analogue-suppressed Chronic Hepatitis B
Sintilimab, Pegylated Interferon-α 2b, Nucleos(t)ide Analogues - Chronic Hepatitis B
Not applicableNot yet recruitingBeijing 302 Hospital602026-09-012026-09-09
A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B
Nucleos(t)ide Analogues, Interferon alfa, NAs combined with IFNα - HBV, Chronic Hepatitis b
Not yet recruitingBeijing 302 Hospital20002025-05-012025-04-29
Extension Study of Carvedilol RCT Study
Carvedilol 12.5 MG - Liver Cirrhosis, Portal Hypertension
Not applicableUnknownBeijing Friendship Hospital2402021-01-082021-08-25
Carvedilol for Prevention of Esophageal Varices Progression
Carvedilol - Cirrhosis, Liver, Portal Hypertension
Not applicableUnknownBeijing Friendship Hospital2402017-10-092022-12-01
Improvement of Hard Endpoint in Chronic Hepatitis B Patients Treated With Antiviral Therapy
Nucleos(t)ide Analogues - Chronic Hepatitis B
UnknownBeijing Friendship Hospital6002016-01-012021-04-14

Conditions studied

Hepatitis B, Chronic (3)  ·  Liver Cirrhosis (3)  ·  Esophageal and Gastric Varices (2)  ·  Hypertension, Portal (2)

Sponsors

Beijing Friendship Hospital (3)  ·  Beijing 302 Hospital (2)

Countries

China (5)

Top investigators

Xiaojuan Ou (2)  ·  Dong J Jia, Doctor (1)  ·  Fusheng Wang (1)  ·  Junliang Fu (1)

Results publications

PMID 33460002, PMID 37929952